Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2009 1
2011 1
2015 1
2016 1
2019 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Peritoneal Surface Disease Finding"
Page 1
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline.
Tew WP, Lacchetti C, Ellis A, Maxian K, Banerjee S, Bookman M, Jones MB, Lee JM, Lheureux S, Liu JF, Moore KN, Muller C, Rodriguez P, Walsh C, Westin SN, Kohn EC. Tew WP, et al. J Clin Oncol. 2020 Oct 20;38(30):3468-3493. doi: 10.1200/JCO.20.01924. Epub 2020 Aug 13. J Clin Oncol. 2020. PMID: 32790492 Free PMC article.
PURPOSE: To provide recommendations on the use of poly(ADP-ribose) polymerase inhibitors (PARPis) for management of epithelial ovarian, tubal, or primary peritoneal cancer (EOC). METHODS: Randomized, controlled, and open-labeled trials published from 2011 through 2020 were …
PURPOSE: To provide recommendations on the use of poly(ADP-ribose) polymerase inhibitors (PARPis) for management of epithelial ovarian, tuba …
Endometriosis: New Perspective for the Diagnosis of Certain Cytokines in Women and Adolescent Girls, as Well as the Progression of Disease Outgrowth: A Systematic Review.
Toczek J, Jastrzębska-Stojko Ż, Stojko R, Drosdzol-Cop A. Toczek J, et al. Int J Environ Res Public Health. 2021 Apr 29;18(9):4726. doi: 10.3390/ijerph18094726. Int J Environ Res Public Health. 2021. PMID: 33946650 Free PMC article. Review.
Currently, diagnosis of this mysterious chronic illness relies on performing a laparoscopic procedure with tissue sampling. ...A recent publication aims to reveal a new prospect for the non-invasive diagnosis, detection, and estimation of certain biomarkers for much …
Currently, diagnosis of this mysterious chronic illness relies on performing a laparoscopic procedure with tissue sampling. ...A rece …
Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.
Jaaback K, Johnson N, Lawrie TA. Jaaback K, et al. Cochrane Database Syst Rev. 2016 Jan 12;2016(1):CD005340. doi: 10.1002/14651858.CD005340.pub4. Cochrane Database Syst Rev. 2016. PMID: 26755441 Free PMC article. Review.
BACKGROUND: Ovarian cancer tends to be chemosensitive and confine itself to the surface of the peritoneal cavity for much of its natural history. ...SELECTION CRITERIA: The analysis was restricted to randomised controlled trials (RCTs) assessing women with a new …
BACKGROUND: Ovarian cancer tends to be chemosensitive and confine itself to the surface of the peritoneal cavity for much of i …
Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.
Jaaback K, Johnson N. Jaaback K, et al. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005340. doi: 10.1002/14651858.CD005340.pub2. Cochrane Database Syst Rev. 2006. PMID: 16437527 Updated. Review.
BACKGROUND: Ovarian cancer tends to be chemosensitive and confine itself to the surface of the peritoneal cavity for much of its natural history. ...SELECTION CRITERIA: The analysis was restricted to randomised controlled trials assessing women with a new diagnos …
BACKGROUND: Ovarian cancer tends to be chemosensitive and confine itself to the surface of the peritoneal cavity for much of i …
Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.
Jaaback K, Johnson N, Lawrie TA. Jaaback K, et al. Cochrane Database Syst Rev. 2011 Nov 9;(11):CD005340. doi: 10.1002/14651858.CD005340.pub3. Cochrane Database Syst Rev. 2011. PMID: 22071822 Free PMC article. Updated. Review.
BACKGROUND: Ovarian cancer tends to be chemosensitive and confine itself to the surface of the peritoneal cavity for much of its natural history. ...SELECTION CRITERIA: The analysis was restricted to randomised controlled trials (RCTs) assessing women with a new …
BACKGROUND: Ovarian cancer tends to be chemosensitive and confine itself to the surface of the peritoneal cavity for much of i …
Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results.
Chua TC, Robertson G, Liauw W, Farrell R, Yan TD, Morris DL. Chua TC, et al. J Cancer Res Clin Oncol. 2009 Dec;135(12):1637-45. doi: 10.1007/s00432-009-0667-4. Epub 2009 Aug 23. J Cancer Res Clin Oncol. 2009. PMID: 19701772 Review.
BACKGROUND: Advanced and recurrent ovarian cancer results in extensive spread of tumor on the peritoneal surfaces of the abdomen and pelvis. We collectively review studies in the literature that report the efficacy of cytoreductive surgery (CRS) and hyperthermic int …
BACKGROUND: Advanced and recurrent ovarian cancer results in extensive spread of tumor on the peritoneal surfaces of the abdom …
A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei.
Yan TD, Black D, Savady R, Sugarbaker PH. Yan TD, et al. Ann Surg Oncol. 2007 Feb;14(2):484-92. doi: 10.1245/s10434-006-9182-x. Epub 2006 Oct 12. Ann Surg Oncol. 2007. PMID: 17054002 Review.
Only observational studies were available for evaluation, which demonstrated some promising long-term results, as compared to historical controls. Due to the rarity of this disease, a well-designed prospective multi-institutional study would be meaningful....
Only observational studies were available for evaluation, which demonstrated some promising long-term results, as compared to historical con …
The role of HIPEC in the treatment of peritoneal carcinomatosis from gastric cancer: between lights and shadows.
Di Vita M, Cappellani A, Piccolo G, Zanghì A, Cavallaro A, Bertola G, Bolognese A, Facchini G, D'Aniello C, Di Francia R, Cardì F, Berretta M. Di Vita M, et al. Anticancer Drugs. 2015 Feb;26(2):123-38. doi: 10.1097/CAD.0000000000000179. Anticancer Drugs. 2015. PMID: 25406023
Despite being the cause of 60% of deaths from gastric cancer, peritoneal metastasis can still be considered a local disease and a local multidisciplinary approach can improve the prognosis even in this end-stage disease. At present, hyperthermic intraperitone …
Despite being the cause of 60% of deaths from gastric cancer, peritoneal metastasis can still be considered a local disease an …
Performance of prediction models on survival outcomes of colorectal cancer with surgical resection: A systematic review and meta-analysis.
He Y, Ong Y, Li X, Din FV, Brown E, Timofeeva M, Wang Z, Farrington SM, Campbell H, Dunlop MG, Theodoratou E. He Y, et al. Surg Oncol. 2019 Jun;29:196-202. doi: 10.1016/j.suronc.2019.05.014. Epub 2019 May 20. Surg Oncol. 2019. PMID: 31196488 Free article.
We identified five models (Basingstoke score, Fong score, Nordinger score, Peritoneal Surface Disease Severity Score and Valentini nomogram) that were validated in at least two external datasets with a median summarized C-statistic of 0.67 (range: 0.57-0.74). …
We identified five models (Basingstoke score, Fong score, Nordinger score, Peritoneal Surface Disease Severity Score an …